INOVIO Schedules Second Quarter Financial Results for August 12

Investors are looking toward August 12, when Plymouth Meeting-based INOVIO will disclose its financial performance for the second quarter of 2026. The biotechnology firm, which specializes in DNA-based treatments for HPV-related conditions and oncology, plans to pull back the curtain on its fiscal standing immediately following the market close.

Yesterday, 23:16· Corp and Tech· 623 reads

Following the release of the quarterly figures, company leadership will host a live conference call and webcast at 4:30 p.m. ET. The session is designed to provide a comprehensive business update alongside the financial review. While the event is strictly listen-only for the general public, it will feature a live question-and-answer segment specifically for analysts.

Those interested in the proceedings can access the live stream through the company’s investor relations portal. The recording will remain available for replay for 90 days following the presentation. INOVIO continues to advance its proprietary technology, which focuses on engineering DNA medicines that prompt the human body to generate its own therapeutic defense mechanisms.

INOVIO Schedules Second Quarter Financial Results for August 12

Comments (0)